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In the 1950s, the Mayak nuclear weapons facility in Russia discharged liquid radioactive wastes into the Techa River causing exposure
of riverside residents to protracted low-to-moderate doses of radiation. Almost 10000 women received estimated doses to the
stomach of up to 0.47 Gray (Gy) (mean dose¼0.04Gy) from external g-exposure and
137Cs incorporation. We have been following
this population for cancer incidence and mortality and as in the general Russian population, we found a significant temporal trend of
breast cancer incidence. A significant linear radiation dose–response relationship was observed (P¼0.01) with an estimated excess
relative risk per Gray (ERR/Gy) of 5.00 (95% confidence interval (CI), 0.80, 12.76). We estimated that approximately 12% of the 109
observed cases could be attributed to radiation.
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The female breast is recognised as one of the most radiation-
sensitive organs and exposure to ionising radiation appears to play
a role in both the initiation and promotion of breast cancer
(UNSCEAR, 2000). Increased risk of breast cancer was reported in
women exposed to multiple X-ray examinations (Boice et al, 1991;
Doody et al, 2000), radiotherapy (Hildreth et al, 1989; Mattsson
et al, 1993; Lundell et al, 1999) and radiation from the atomic
bombings in Japan (Land et al, 2003; Preston et al, 2007). The
atomic bombings and fractionated medical X-radiation are
characterised by acute, high-dose rate g-radiation. In a pooled
analysis of several cohorts, an excess relative risk (ERR) per Gray
(Gy) of 0.86 (95% confidence interval (CI), 0.7, 1.04) was reported
with individual study risks ranging from 0.06 to 1.94 (Preston et al,
2002).
In contrast, risks from exposure to chronic low-dose rate
radiation have rarely been quantified due to a lack of adequate
dose estimates. Associations between cancer risks from low-dose
occupational radiation exposure (Wang et al, 2002; Doody et al,
2006) or protracted low-to-moderate dose environmental radiation
exposure (Bauer et al, 2005; Pukkala et al, 2006) have, however,
been reported.
In this paper, we report on the breast cancer experience among
women who were exposed to protracted low-dose rate external and
internal radiation from discharges of radioactive waste into the
Techa-Iset river system from the Mayak nuclear weapons facility in
the Southern Urals region of Russia. These releases primarily
occurred between 1950 and 1960, affecting tens of thousands of
inhabitants of riverside villages. The study was reviewed and
approved by the institutional review board at the Urals Research
Center for Radiation Medicine (URCRM).
MATERIALS AND METHODS
Study cohort
The Techa River Incidence cohort (TRIC) consists of 18382
individuals born before 1950, who lived in villages on the Techa
River in Chelyabinsk Oblast at some time between January 1950
and December 1960. The current analyses are based on the 9908
female cohort members with follow-up from 1956–2004. The study
cohort and follow-up period were defined on the basis of the
cancer incidence data availability.
The discharge of radioactive wastes into the Techa-Iset
river system was the source of a substantial radiation exposure.
The total volume of radioactive wastes discharged by the Mayak
facility amounted to 76 million m
3 with a total activity of 10
17 Bq
(2.75 million Ci) for b-emitters (Akleyev and Lyubchansky, 1994).
About 95% of the total activity was released into the Techa River
from March 1950 through November 1951. The primary radio-
nuclides released were
137Cs and the bone-seeking isotopes of
strontium (
89Sr and
90Sr), which accounted for 12.2 and 20.4% of
the total discharge, respectively (Degteva et al, 1994).
Residents of the riverside areas received both external and
internal radiation exposures. External exposures to g-radiation
were primarily from
137Cs, with some additional exposure from
Received 26 August 2008; revised 13 October 2008; accepted 17
October 2008; published online 11 November 2008
*Correspondence: Dr E Ostroumova; Laboratory of Epidemiology , Urals
Research Center for Radiation Medicine, 68-a Vorovsky St, Chelyabinsk
454076, Russia; E-mail: zhenia@urcrm.chel.su
5Current address: 656 Lytton Avenue, Palo Alto, CA 94301, USA
British Journal of Cancer (2008) 99, 1940–1945


















90Sr for drinking, cooking
and other domestic needs (Degteva et al, 1994). Details of the
Techa River Dosimetry System (TRDS-2000) used to reconstruct
external and internal doses are published elsewhere (Degteva et al,
2000a,b; Jacob et al, 2003). Exposure of soft tissues, including
breast, was largely from external g-radiation and internal
g-radiation from
137Cs distributed uniformly through the body.
In the absence of individual breast dose estimates, individualised
estimates of doses to the stomach are used as an approximation of
dose to breast. The TRDS-2000 provides annual dose estimates
based primarily on age- and village-specific group means that were
individualised to account for the periods of residence in
contaminated villages. The maximum estimated dose to the
stomach was 0.47Gy (mean¼0.04 Gy; median¼0.01Gy).
Considerable migration among study cohort members because
of compulsory re-settlement from highly contaminated to
uncontaminated villages, and migration of younger cohort
members primarily for educational or job opportunities presented
a challenge in follow-up and therefore most work has focused on
mortality data (Kossenko et al, 2005; Krestinina et al, 2005).
Information on date and place of death, current residence and the
date and place of migration of cohort members was obtained
through periodic queries to the Address Bureaus of Chelyabinsk
and Kurgan Oblasts. Because of the difficulties in obtaining cancer
incidence data, we limited follow-up to the five rayons (districts) in
Chelyabinsk Oblast where many of the exposed subjects resided
and to Chelyabinsk city. These six geographic areas are considered
the cancer incidence study catchment area.
Reporting of newly diagnosed malignancies to the Regional
Oncology Dispensaries using notification forms became manda-
tory in the former Soviet Union in 1956. URCRM staff have
systematically collected copies of cancer notification forms for
residents of the study catchment area. As the probability of
identifying a cancer case depended on a cohort member living in
the study catchment area, only breast cancers diagnosed while the
patient lived in the catchment area are included in the analysis.
Cohort members are treated as lost to follow-up when they migrate
from the catchment area (Kossenko et al, 2005; Krestinina et al,
2007).
Basic personal identifiers (last name, first name and father’s first
name, birth date, place of birth) are used for matching cancer case
notifications to the TRIC. Copies of death certificates for deceased
cohort members are obtained from the Regional Vital Statistics
Registrar’s Office archives. Additional information on cohort
members who developed breast cancer is obtained from their
medical charts stored at the URCRM clinical department.
Statistical methods
Analyses were based on a detailed classification of person-years
and case counts stratified by ethnic group (Slavs and Tartars/
Bashkirs), attained age (5-year groups through age 79 and 80 plus),
follow-up period (5-year periods from 1956 through 2004), age at
first exposure (10-year groups through age 59 and 60 plus), time of
study entry (before and after 1.1.1953), number of live births
(nulliparous, 1–2, X3 children and unknown), age at first
pregnancy (o25, X25 years and unknown), and stomach dose
(in Gy) with 5-year latency period, that is, dose received in p5
years prior to cancer diagnosis was not considered in assessing
breast cancer risk. The first 6 years of follow-up (1950–1955) were
excluded from analysis, because cancer incidence data were not
available. Women contributed person-years only when they were
known to reside in the catchment area, as this reflected when a
woman was at risk of having a breast cancer identified. Person-
year accumulation began on 1 January 1956 or from the initial date
of residence in a contaminated village after that date. The
termination date for counting person-years was the date of death,
or the earliest of the following: date of last known residence in the
catchment area, or of breast cancer diagnosis, or 31 December
2004. Person-year computations and risk estimation were carried
out using Epicure software (Preston et al, 1993).
Statistical analyses and calculation of risk coefficients were
based on both external and internal comparisons. For the external
comparisons, the number of expected cases was calculated using
both general and rural Russian female population age- and
calendar-period-specific incidence rates (Tserkovnyi et al, 1975;
Napalkov et al, 1982; Merabishvili et al, 1984; Dvoirin et al, 1991;
Dvoirin and Aksel, 1992; Chissov and Starinskii, 2000; Chissov
et al, 2006). The ratio between observed and expected number of
cancers, the standardised incidence ratio (SIR) was calculated with
95% CIs assuming a Poisson distribution.
Breast cancer incidence rates in the cohort were analysed
using simple parametric excess relative risk (ERR) models. The
basic ERR model for age-specific breast cancer incidence rates was
l(a, d, z)¼l0(a, z0)(1þr(d)e(z1)) where a is age at diagnosis, d is
stomach dose in Gy, z0 represents factors (such as birth cohort,
parity, age at first full-term pregnancy, ethnicity or date of arrival
on the contaminated area) that could modify the baseline rates
(l0), and z1 represents factors that could modify the ERR. For
analyses based on external comparisons the baseline rates were
taken to be equal to the yRpop(a,y), where Rpop(a,y) is the
population rate for age a in year y, and y is the estimated baseline
SIR. For analyses based on internal comparisons, a log linear
model was used to estimate baseline (zero-dose) risk with the rates
to be proportional to age to a power that changes once women
reach the age of 50 years. Ethnicity, number of live births, time of
study entry and birth cohort were considered as potential
modifiers of the baseline rates.
The dose–response function was generally taken as a linear
function of dose (r1d). Tests for non-linearity in the
dose–response were based on comparison of the linear and
linear-quadratic dose–response models (r1dþr2d
2). Because of
the small number of observed and radiation-associated cases in
this cohort, there is little power to assess effect modification. The
primary analysis was based on a dose–response model without
effect modification. However, we evaluated several factors that
might modify the association between radiation and breast cancer,
namely, age at exposure, ethnicity and age at diagnosis.
Parameter estimates were obtained using Poisson regression
maximum likelihood analyses of rates in the detailed rate tables
described above. Significance tests and CIs were determined
directly from the likelihood. All P-values refer to two-sided tests.
RESULTS
Over 37 years (1956–2004), 109 breast cancers were diagnosed
among TRIC members, of which 79% were histologically
confirmed, 16% by X-ray and clinical examinations, and 5% solely
from death certificates.
The majority of cohort members reported Slavic ethnicity
(67%), 42% of women were less than 20 years old at the start of
exposure, and 79% lived along the river during the period of
maximum releases (i.e., 1950–1952). At the end of follow-up 19%
of the cohort were urban residents. The estimated stomach doses
were below 5mGy for 30% of the cohort members, whereas 16%
had a dose of 50mGy and over.
Table 1 summarises the follow-up status of the study cohort. The
9908 study subjects have a total of 270289 person-years of follow-
up in the catchment area during the study period. At the end of the
follow-up period, 2115 (21%) cohort members were known to have
migrated from the catchment area. Owing to lack of complete
cancer incidence data outside the catchment area, as well as the
differences in follow-up within and outside this area (vital status
unknown for 37% of migrants vs 8% of non-migrants; cause of
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ydeath unknown for 41% of deceased outside vs 13% of deceased
within the catchment area), the analyses were limited to the
periods in which cohort members were known to reside in the
catchment area.
Table 2 shows crude breast cancer incidence rates and adjusted
relative risks by follow-up period. The crude rates increased with
follow-up period primarily due to the aging of the cohort. The
increase in baseline incidence rates prior to and after 50 years of
age was proportional to the 6.8 and 1.1 power of age, respectively.
After adjusting for attained age, we found a marked birth cohort
effect (Po0.001) with rates increasing on average by 50% (95% CI:
28; 87%) per decade increase of birth year. Without allowing for
possible radiation dose effects, the number of cases was 37% more
than predicted national rates for rural areas (109 observed vs 79.6
expected, SIR¼1.37; 95% CI: 1.13; 1.65). However, when
compared with general female population rates the observed
number of cases was 19% lower than expected (109 vs 135.3,
SIR¼0.81; 95% CI: 0.67; 0.97). Allowing for a linear dose–
response, the baseline SIRs were somewhat lower, with estimates of
1.26 (rural) (95% CI: 1.01; 1.58) and 0.74 (general) (95% CI: 0.59;
0.93), respectively. Breast cancer SIRs based on Russian general
and rural female population rates by follow-up period are
presented in Figure 1.
Table 3 summarises relative risk estimates for selected non-
radiation risk factors. Background breast cancer risk among Tartar
and Bashkir was 34% lower than Slavic women (P¼0.06). A
significantly higher risk was found among women who arrived on
the Techa River between 1953 and 1960 (i.e., late entrants)
compared with those who lived in the area during the period of
maximal radioactive contamination. The highest breast cancer risk
was found in nulliparous women compared with women who had
three or more children (P¼0.008). Among parous women, there
was no difference in risk by age at first birth (P¼0.43).
A significant (P¼0.01) linear dose–response relationship was
observed for breast cancer with little evidence of non-linearity
(P40.5). The estimated ERR/Gy was 4.99 (95% CI: 0.80; 12.76).
Table 4 summarises the distribution of cases, person-years and
fitted values in 5-year lagged cumulative dose categories.
Under a linear dose–response model, it was estimated that
12.4% (95% CI: 2.3; 25.5%) of the breast cancers observed were
attributable to radiation exposure. The small number of breast
cancers limited the ability to detect effect modification. Ethnicity,
age at diagnosis, age at exposure and time since exposure did not
significantly modify the breast cancer radiation risk estimate;
however, women who were under age 10 at first exposure appeared
to have the highest risk (data not shown).
DISCUSSION
This is the first report describing breast cancer incidence patterns
and radiation dose relations in a subgroup of the Techa River
cohort. The main result from our study was a significant linear
relationship between breast cancer incidence and radiation dose.
This finding adds to the limited data on the carcinogenic effects
from protracted environmental ionising radiation in the low-to-
medium dose range.
As neither Techa River residents nor health care providers were
aware of dose levels and given the legal requirement for newly
diagnosed malignancies to be reported to the Regional Oncology
Dispensary, the likelihood of differential reporting for patients
with high and low exposure is small. The power of the study is
Table 1 Distribution of vital status in the Techa River Incidence female cohort by residence for subjects with and without breast cancer (follow-up period
1.1.1956–31.12.2004)
Vital status as of 31.12.2004 Cancer incidence catchment area
a (%) Outside the catchment area (%) Total (%)
Non cases (n¼9777)
Alive 2666–34.2 611–28.9 3277–33.1
Dead 4372–56.1 701–33.1 5073–51.2
Cause known 3820–87 412–59 4232–83
Cause unknown 552–13 289–41 841–17
Current vital status unknown 646–8.3 781–36.9 1427–14.4
Breast cancer cases (n¼131)
Alive 41 4 45
Dead 66 18 84
Cause known 62 17 79
Cause unknown 4 1 5
Current vital status unknown 2 0 2
Total 7793–100 2115–100 9908–100
Person-years 270289 57684 327973
aCancer incidence catchment area includes four rayons through which Techa River flows (Kaslinsky, Krasnoarmeysky, Kunashaksky and Argayshsky) and Sosnovsky rayon where
many exposed residents were resettled and Chelyabinsk city to which many of the cohort members moved.
Table 2 Breast cancer incidence rates and relative risks by times of tumour diagnosis in the Techa River Incidence female cohort
Follow-up period Number of cases Number of person-years Mean age, years






1956–1969 13 108300 39.4 12.0 (7.0–20.7) 1.0
1970–1979 14 61056 48.9 22.9 (13.6–38.7) 1.3 (0.6–2.9)
1980–1989 30 48847 55.7 61.4 (42.9–87.8) 2.86 (1.5–5.5)
1990–2004 52 52086 63.5 99.8 (76.17–131.0) 3.9 (2.1–7.7)
1956–2004 109 270289 49.1 40.3 (33.4–48.7)
aRelative risk adjusted for age at diagnosis, ethnicity, number of children, time of arrival on the contaminated territory (before and after 1953) and 5-year lagged cumulative
stomach dose based on linear ERR model.
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ydecreased by the reduction in person-years of follow-up because of
relatively high migration from the study catchment area. Because
of the nature of the address and cancer registration systems it is
not possible to obtain complete information on cancer incidence,
vital status or cause of death for cohort members living outside the
study catchment area. For cohort members living in the study
catchment area, vital status at the end of follow-up was known for
92% and among deceased subjects cause of death was ascertained
for 87% (Table 1). However, vital status at the end of follow-up was
known for only 63% of cohort members who had left the
catchment area and cause of death was known for only 60% of
the identified. Therefore, analyses were limited to periods in
which subjects were known to reside in the study catchment area.
The loss to follow-up reduces the study’s statistical power to detect
a dose–response and assess effect modification. It could introduce
some bias, but as there is no indication that the loss to follow-up is
dose-related, bias is unlikely. In our study, 79% of breast cancers
had histological confirmation and 5% were identified only through
death certificates. This is comparable with the respective indices in
Eastern Europe cancer registries (IARC, 1992).
We found a significant increase of breast cancer background
risk with attained age, nulliparity, and follow-up time, as in the
general Russian population and worldwide (Remennick, 1989;
Zaridze and Basieva, 1990; IARC, 1993). Although national data are
limited, the striking birth cohort effect in our study appears to be
consistent with that in the Russian Federation as a whole during
this period (Tserkovnyi et al, 1975; Napalkov et al, 1982;
Merabishvili et al, 1984; Dvoirin et al, 1991; Dvoirin and Aksel,
1992; Chissov and Starinskii, 2000; Chissov et al, 2006).
The failure to find a significant effect of age at first full-term
pregnancy can be attributed to the fact that 97% of women in our
study were under 30 years of age at the time of their first full-term
pregnancy. After adjustment for the number of live births, the
difference between the two ethnic groups (Slavs vs Tartars and
Bashkirs) was marginally significant (P¼0.06) suggesting that this
is largely because of different reproductive patterns (Remennick,
1989). The reason for higher background breast cancer risk among
late entrants compared with women resident in the Techa area in
1950–1952, is not clear and requires further investigation.
We recognise the possible underascertainment of breast cancers
in our cohort because of the retrospective nature of our follow-up,
most likely in women 70 years and older. Breast cancer SIR
estimates were somewhat higher (SIR¼1.37; 95% CI: 1.13; 1.65)
using Russian rural rates, and lower (SIR¼0.81; 95% CI: 0.67;
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Figure 1 Standardised Incidence Ratios (SIRs) and 95% confidence
intervals (CIs) for breast cancer for the Techa River female population
compared with Russian general (open circles) and rural (black circles)
female populations by follow-up period. Lines represent overall SIR
estimate for the Techa River female population compared with Russian
rural (upper, dot-dashed line) and Russian general (lower, dashed line)
female populations. x axis – Follow-up year; y axis – SIR.
Table 3 Breast cancer incidence risk estimates
Risk factor Cases n¼109 PYR n¼270289 RR
a 95% CI
Ethnicity
Slavs 78 165456 1.0 Referent
Tartars & Bashkirs 31 104833 0.7 0.4–1.0
P for homogeneity 0.06, d.f.¼1
Subcohort
OTRC
b 82 221848 1.0 Referent
Late entrants 27 48441 1.7 1.03–2.6
P for homogeneity 0.04, d.f.¼1
Attained age, years:
o45 12 110730 0.1 0.1–0.2
45–54 33 52585 1.0 Referent
55–64 34 50453 1.3 0.8–2.2
65+ 30 56521 1.7 1.0–3.0
P for homogeneity o0.001, d.f.¼3
Number of children born
c
3+ 36 124060 1.0 Referent
1–2 53 104546 1.8 1.1–2.7
Nulliparous 19 36483 2.2 1.2–3.8
P for homogeneity 0.008, d.f.¼2
Age at first pregnancy
c
o20 years 8 27123 1.0 Referent
X20 years 81 200998 1.3 0.7–3.0
P for homogeneity 0.43, d.f.¼1
aRelative risk adjusted for age at diagnosis, ethnicity, number of children, age at first
pregnancy, time of arrival on the contaminated territory (before and after 1953),
linear birth cohort effect and 5-year lagged cumulative stomach dose based on linear
ERR model.
bOTRC¼Original Techa River Cohort (resident in the Techa area in
1950–1952).
cOne case with unknown information on live birth and age at first
pregnancy is excluded from analysis.
Table 4 Breast cancer 1956–2004 by stomach dose category
Dose




o5.0 67631 25 30.7 0.3 (0.04–0.6) 1.2 (0.2–2.4)
5–9.9 75460 37 29.7 1.0 (0.2–2.1) 2.7 (0.5–5.7)
10–24.9 41377 8 10.5 1.1 (0.2–2.2) 13.7 (2.5–27.5)
25–49.9 48453 19 14.4 2.0 (0.4–4.1) 10.5 (2.1–21.6)
50+ 37368 20 10.1 9.1 (1.7–18.7) 45.5 (8.5–93.5)
Total 270289 109 95.5 13.5 (2.5–27.8) 12.4 (2.3–25.5)
a5-year lagged cumulative stomach dose.
bEstimates of the number of background and radiation-associated excess cases based on a linear ERR model after background rates
adjustment for effects of age, number of children, time of arrival on the contaminated territory (before and after 1953) and linear birth cohort effect.
cAR–attributable risk
estimated as the ratio of the number radiation-associated excess cases over the total number of cases in each stomach dose category.
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yOne of the main limitations in our study was the relatively low
statistical power for quantifying how the radiation risk varies with
age at exposure, age at diagnosis and ethnicity. Although it is
significant, the point estimate of the ERR per Gy of 4.99 is quite
uncertain with 95% CI, 0.80, 12.76. Although the TRDS-2000 does
not provide breast dose estimates, because of the nature of the soft
tissue exposures (external g-ray exposures and internal exposure
to g-rays from
137Cs distributed uniformly throughout the body),
the breast and stomach doses should be similar. TRDS-2000 dose
estimates should not be considered definitive, as efforts are
currently underway to improve the dosimetry system by better
characterisation of the radiation source term and using more
information to individualise dose estimates (Degteva et al, 2006).
On account of the overlapping CIs, our risk estimate, though
higher, is comparable with the ERR of 0.86/Gy (95% CI: 0.7; 1.04)
found in the pooled analysis of atomic bomb survivors and seven
cohorts of medically irradiated women with 1502 breast cancers
and 1.8 million person-years of follow-up (Preston et al, 2002).
Among the cohorts considered in that study, the highest ERR
(1.94/Gy with a 95% CI of 1.3–2.8) was observed in the Swedish
benign breast disease cohort (mean breast dose¼5.8Gy).
Significantly elevated breast cancer risks were reported for a
cohort of 56436 US radiologic technologists (Doody et al, 2006)
and among 5443 Chinese female X-ray workers (Wang et al, 2002)
who experienced daily, small radiation doses over many years. In
both of these cohorts the highest relative risks appeared to be
among women who were younger at the time of initial exposure. A
meta-analysis of breast cancer incidence among female flight
attendants suggested a significant increase in risk due to
occupational exposure to cosmic radiation (Tokumaru et al,
2006). Rafnsson et al (2001) also found an increased breast cancer
risk among 1690 flight attendants with 26 breast cancers
(SIR¼1.5, 95% CI: 1.0; 2.4) at the mean annual radiation dose
of about 3mSv. The authors suggested that the doses appeared to
be too low to explain the increased risk and stated that adjustment
for other occupational hazards (e.g., exposure to chemicals,
irregular work hours etc.) was necessary.
Analysis of 61 breast cancers in almost 5000 women exposed to
radiation from nuclear testing fallout in Kazakhstan (mean
effective dose¼634mSv), provided an ERR of 1.09/Sv (95% CI:
 0.05; 15.8) (Bauer et al, 2005). A study of breast cancer incidence
after the Chernobyl accident found an increased risk among
women resident in the most contaminated districts (average
cumulative whole body dose of 50mSv) with an ERR of 1.2 (95%
CI, 0.5, 2.3) in Belarus and 0.8 in Ukraine (95% CI: 0.1; 1.9).
However, the limitations of ecologic studies require that this
finding be interpreted with caution (Pukkala et al, 2006).
Our study findings are in agreement with the hypothesis of
linearity of radiation dose–response for breast cancer. The point
estimate of the ERR per Gy is higher than that reported by others,
but given our wide risk CIs, it is consistent with many other
studies. Current dose estimates have limitations that could bias
ERR estimates (Degteva et al, 2006). Planned improvements to the
dosimetry system include: (1) use of modified source term based
on information on the timing and composition of the Mayak
nuclear facility releases: (2) taking account of the precise location
of subjects’ residence rather than the current use of a representa-
tive location for each village (an important factor for external
dose); (3) using improved information on an individual’s source of
drinking water (affecting internal dose); (4) making more direct
use of individual whole body count data in estimation of internal
doses; (5) taking into account other sources of radiation exposure,
such as the 1957 Kyshtym accident, radioactive gaseous aerosol
releases from the Mayak nuclear facility, and exposure from
radiological medical examinations. Although these changes will
reduce uncertainty of individual dose estimates, they are not
expected to substantially modify risk estimates.
In summary, an analysis of breast cancer incidence among
women in the Techa River Incidence Cohort has shown a
significant increase with age at diagnosis, birth cohort and
reduction in incidence with increasing parity. A significant linear
trend of risk with increasing radiation dose, is based on small
numbers and requires cautious interpretation.
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